6
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Radiosensitization by the 2,4-dinitro-5-aziridinyl Benzamide CB 1954: A Structure/Activity Study

, &
Pages 31-41 | Received 23 May 1986, Accepted 08 Jan 1987, Published online: 03 Jul 2009
 

Summary

CB 1954 (2,4-dinitro-5-aziridinyl benzamide) is a radiosensitizer which is up to 10 times more efficient in vitro than would be predicted on the basis of its electron affinity. In order to determine the contribution of the various functional groups comprising the molecule to overall sensitizing efficiency, nine structural analogues have been studied. The redox potential, E17, and sensitizing efficiency, C1·6, were obtained for each compound. The value of C1·6 depends on both redox potential and the magnitude of an additional component defined by Ĉ1·6/C1·6, where Ĉ1·6 is derived from a structure/activity relationship (Adams et al. 1979 b, Wardman 1982) described by the equation:

The magnitude of Ĉ1·6/C1·6 for CB 1954 and its analogues depends on alkyl substitution of the amide, the presence/absence and position of the nitro groups and is independent of the presence of the aziridine group. Holding cells in the presence of the drug post-irradiation marginally enhanced sensitization by CB 1954, CB 10–107 and by CB 10–092 but the largest effect was seen with the mononitro compound CB 7060 which also has a value of 26 for Ĉ1·6/C1·6. This compound was also interesting in that when combined with 2-phenyl-4(5)amino-5(4)-imidazole carboxamide (phenyl AIC) an enhancement of sensitization was obtained. In contrast, phenyl AIC protected against radiosensitization by CB 1954.

Taken together, the data suggest that multiple mechanisms of radiosensitization may contribute to the abnormal radiosensitizing efficiency of CB 1954 and its analogues. This has implications for the further design and development of novel radiosensitizing drugs.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.